Cue Biopharma, Inc.CUENASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
12.63%
↑ 251% above average
Average (38q)
-8.39%
Historical baseline
Range
High:39.37%
Low:-107.45%
Volatility
-1750.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 12.63% |
| Q2 2025 | 29.79% |
| Q1 2025 | -27.68% |
| Q4 2024 | -9.28% |
| Q3 2024 | 15.10% |
| Q2 2024 | 18.04% |
| Q1 2024 | 8.42% |
| Q4 2023 | -21.13% |
| Q3 2023 | 15.52% |
| Q2 2023 | -1.02% |
| Q1 2023 | 10.00% |
| Q4 2022 | -34.77% |
| Q3 2022 | 15.73% |
| Q2 2022 | 8.06% |
| Q1 2022 | -80.39% |
| Q4 2021 | 39.37% |
| Q3 2021 | -26.35% |
| Q2 2021 | 17.69% |
| Q1 2021 | -14.06% |
| Q4 2020 | -8.33% |
| Q3 2020 | 7.41% |
| Q2 2020 | 15.80% |
| Q1 2020 | -44.14% |
| Q4 2019 | -27.08% |
| Q3 2019 | 23.15% |
| Q2 2019 | 19.22% |
| Q1 2019 | -4.20% |
| Q4 2018 | 14.05% |
| Q3 2018 | -70.76% |
| Q2 2018 | 0.66% |
| Q1 2018 | 27.94% |
| Q4 2017 | -107.45% |
| Q3 2017 | -14.03% |
| Q2 2017 | -31.73% |
| Q1 2017 | -17.86% |
| Q4 2016 | -40.42% |
| Q3 2016 | -45.01% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |